I have no problem with a OKU cap raising in general and I agree...

I have no problem with a OKU cap raising in general and I agree it is positive that OKU can give full speed now in exploring the promising projects.
But a „bloody good cr“ is when either all shareholders could participate or when sophisticated investors are paying a premium.
The fact that the placement was heavily oversubscribed shows that cap rising price was much too cheap.
At least Cannacord & buddies had obviously so much integrity, to invest today some bucks of their 2 Am$ placement-discount. So it looks at first glance like a placement success story for dilluted smallholders…